Galectin Therapeutics Inc.
GALT
$3.98
-$0.18-4.33%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 85.32% | -50.85% | -44.12% | 5.71% | 8.67% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -10.68% | 80.70% | -36.11% | -4.91% | -11.34% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 66.15% | -46.18% | -39.82% | 5.05% | 7.18% |
|
|||||
Total Current Assets | 66.15% | -46.18% | -39.82% | 5.05% | 7.18% |
Net Property, Plant & Equipment | -99.85% | 312.50% | -38.46% | -25.71% | -22.22% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -1.19% | -22.03% | -18.93% | -15.92% | -13.51% |
Total Assets | 63.75% | -45.54% | -39.61% | 4.76% | 6.82% |
|
|||||
Total Accounts Payable | -10.24% | 15.52% | 102.36% | -24.42% | -2.61% |
Total Accrued Expenses | -29.78% | -16.59% | -29.16% | 6.86% | 23.03% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -99.95% | 361.20% | 100.34% | 23,877.27% | -8.33% |
Total Finance Division Other Current Liabilities | -- | -- | 20.33% | 469.84% | -- |
Total Other Current Liabilities | -- | -- | 20.33% | 469.84% | -- |
Total Current Liabilities | -90.28% | 213.03% | 40.19% | 72.80% | 15.70% |
|
|||||
Total Current Liabilities | -90.28% | 213.03% | 40.19% | 72.80% | 15.70% |
Long-Term Debt | 1,014.21% | -87.14% | -9.49% | 0.66% | 10.77% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -97.82% | 22.39% | -- |
Total Liabilities | 9.02% | 1.02% | -0.73% | 10.61% | 13.23% |
|
|||||
Common Stock & APIC | 0.91% | 0.14% | 0.49% | 0.31% | 0.47% |
Retained Earnings | -1.84% | -2.39% | -3.09% | -2.97% | -3.40% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -4.28% | -8.73% | -11.18% | -12.25% | -15.09% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -0.45% | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -0.45% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|||||
Total Common Equity | -4.28% | -8.73% | -11.18% | -12.25% | -15.09% |
Total Preferred Equity | -0.45% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -4.37% | -8.92% | -11.45% | -12.58% | -15.56% |
|